Subscribe below to get free access to our latest newsletter and watch our product video
Pharmaceutical companies investing in real-world evidence (RWE) to support R&D are reaping the rewards, according to a recent...
Tags: "social media data", "Health 2.0", "RWE",
Greater patient input into drug product design could significantly improve outcomes and save health systems millions, by...
A patient preference study of Crohn’s disease treatments, carried out by Semalytix and partner Boehringer Ingelheim, has won a...
Tags: Semalytix, Pharma, PatientListening,
At Semalytix, we are committed to supporting pharmaceutical companies in their endeavors concerning patient-focused drug...
Tags: AI, Healthcare, Pharma,
The behavior and responsiveness of all companies and brands during the coronavirus crisis will have a big impact on how they...
Tags: "patient listening", Healthcare, COVID19,
Tags: Semalytix, AI, Healthcare,
Patients’ voices are no longer a nice-to-have in drug development. They are a critical determinant of commercial success. As...
Tags: Semalytix, "patient listening", "Health"
People talk about everything online – including health. The pharmaceutical industry can pay attention. The start-up Semalytix...
Improving Pharma’s Ability to Focus on the Needs of Key Stakeholders
Executive Summary
By Melanie Senior, Analyst and Specialist, Writer in Pharma, Life Sciences
Tags: Semalytix
You can allow them to download an ebook, subscribe to your mailing list or book a meeting with sales in exchange for their contact information, turning them into leads for your business.
Semalytix GmbH
Meller Str. 2
33613 Bielefeld
Germany
Call: +49-521-9145-6127
Email: info@semalytix.com
Court of Registration:
Amtsgericht Bielefeld HRB 41831
Value Added Tax ID no.:
DE 300921056
Management Board:
Janik Jaskolski
All rights reserved © 2019 Semalytix GmbH